INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 457m ago
HOUSE PTR57m ago
SEC 13F57m ago
ROBINHOOD CHAIN56m ago
SEC FORM 4/Option exerciseVerified dataRule 10b5-1 plan

Sabar Karimah Es reported CAPR

Director · CAPRICOR THERAPEUTICS, INC. · CAPRICOR THERAPEUTICS, INC. — Stock Option (Right to Buy)

Side
M
Value
—
Shares
61.3K
Price
—
Executed
Mar 31, 2026
Disclosed
Apr 1, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 31 executedApr 1, 2026 disclosed

CAPR · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
0/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CAPR

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    MT
    Maurer Michael TCHIEF COMMERCIAL OFFICER
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    80.0K sh
    		May 26, 2026May 28, 2026
    traded May 26, 2026
    		+2dSEC FORM 4

    Evidence

    0
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M—
    53.7K sh
    		Apr 1, 2026Apr 1, 2026
    traded Apr 1, 2026
    		+0dSEC FORM 4

    Evidence

    5
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M$298K
    61.3K sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    26
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Open-market sale · 10b5-1 plan
    		SELL$1.85M
    61.3K sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    1
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M$261K
    53.7K sh
    		Apr 1, 2026Apr 1, 2026
    traded Apr 1, 2026
    		+0dSEC FORM 4

    Evidence

    22
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Open-market sale · 10b5-1 plan
    		SELL$1.67M
    53.7K sh
    		Apr 1, 2026Apr 1, 2026
    traded Apr 1, 2026
    		+0dSEC FORM 4

    Evidence

    9
    AG
    Auwaerter Paul GisbertDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    15.5K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    KM
    Kelliher MikeDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    15.5K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AG
    Auwaerter Paul GisbertDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    1,360 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AG
    Auwaerter Paul GisbertDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    5,420 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    GJ
    Gotwals Philip JDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    15.5K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    15.5K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001873796-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 31, 2026
    Published
    Apr 1, 2026
    Ingested by INSIDER
    Nov 5, 04:08 UTC
    Last re-read
    Nov 5, 04:08 UTC

    Extracted facts

    Filer
    Sabar Karimah Es
    Role
    Director
    Transaction
    Option exerciseAs filed: “M”
    Asset
    CAPRICOR THERAPEUTICS, INC. — Stock Option (Right to Buy)
    Ticker
    CAPR
    Shares
    61.3K
    Price per share
    $0
    Execution date (reported)
    Mar 31, 2026
    Owned after transaction
    53.7K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    1

    What this establishes

    Sabar Karimah Es filed this Form 4 reporting a option exercise of CAPR on Mar 31, 2026. It became public on Apr 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Sabar Karimah Escik:0001873796
    Issuer
    CAPRICOR THERAPEUTICS, INC.cik:0001133869

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.